Is CBD legal in the UK?

The rule that actually decides it

THC is a controlled drug under the Misuse of Drugs Act 1971 and it does not stop being one because it turns up in a hemp extract. A CBD product sold in a UK shop is therefore legal only because it falls inside a carve-out: the exempt product definition in the Misuse of Drugs Regulations 2001. That definition, not the hemp regulations and not the food regulations, is what makes the jar on the shelf lawful.

The carve-out has three limbs, and most guides quote only the third. A preparation is exempt when it is not designed for administering a controlled drug to a person or an animal; when any controlled drug it contains cannot be recovered by readily applicable means, or in a yield that poses a risk to health; and when no single component part of it holds more than one milligram of that controlled drug.

All three have to hold at once. That matters more than it sounds. The first two limbs are why CBD flower and bud remain a problem in the UK even when a lab says the THC is negligible: dried cannabis flower is quite plainly designed to administer what is in it, and what is in it is recoverable by anyone with a grinder. The third limb is the number everyone quotes, and it is the one you can actually check on a certificate of analysis.

Read the third limb closely and you will notice it counts milligrams, not proportions, and it counts them against the pack rather than the dose. A 100ml bottle gets exactly the same one-milligram allowance as a 10ml one. Nothing in the wording scales the ceiling up for a larger container, which is precisely why big-format products are the hard ones to make compliant, and why we flag full spectrum on every listing that carries it.

Why a percentage and a milligram cannot be the same rule

Here is the arithmetic nobody in this corner of the internet seems willing to write down. A percentage is a ratio, so what it permits grows with the size of the thing you apply it to. A milligram ceiling is a fixed quantity, so it does not grow at all. Apply both to the same bottle and they diverge immediately.

Take a 10ml bottle of CBD oil, which weighs roughly ten grams. Nought point two per cent of ten grams is 0.02 grams, and 0.02 grams is twenty milligrams. The container rule allows one. So the version of the law you keep reading, if anyone actually enforced it as a consumer test, would permit about twenty times the THC that is genuinely lawful in that bottle. Scale the container up and the gap scales with it.

This is not a technicality or a matter of interpretation. It is the difference between a compliant product and a controlled drug, and it is why UK Border Force has seized CBD consignments that arrived with a percentage-based certificate attached. A certificate that reports a proportion and stops there has not answered the question the law asks. The only figure that settles it is the total weight of controlled cannabinoids in the container, in milligrams.

If a retailer tells you their product is compliant because it sits below a certain percentage, they have told you something true about the plant and nothing at all about the pack. Ask them for the milligram total instead. A brand that tests properly will have it, because their own lab reports it.

Where the farming figure came from, and why it stuck

Industrial hemp is grown in the UK under a Home Office licence, and part of that licence is a restriction on which seed varieties a grower may sow. Approved varieties are ones bred to produce very little THC in the standing crop, and the threshold for that list is expressed as a proportion of dry plant weight. That is the origin of the figure. It is a farming control, written to distinguish a fibre and seed crop from a drug crop while it is still in the ground.

The threshold has been moving. The Advisory Council on the Misuse of Drugs recommended raising it in October 2024 to bring the UK into line with the European Union, the United States and Canada, and the government confirmed its support for the change in February 2025, alongside a wider overhaul that lengthened licence terms for growers. We have deliberately not pinned a number to it here, because the number is in flux and, more importantly, because it has never had anything to do with what you can legally be sold.

So why is it everywhere? Because it is a single memorable figure, it sounds like a safety standard, and it was copied from one product page to the next until it became the industry's received wisdom. It appears today on pages that rank in the top ten for this exact question, sometimes presented as an alternative to the container rule, as though a seller could pick whichever suits them. There is no such choice. A product that clears the farming threshold and holds thirty milligrams of THC in the bottle is a controlled drug, and the grower's licence does not travel with the extract.

Novel Foods: the second gate, and only for things you swallow

Clearing the container rule makes a product lawful to possess and supply. It does not, on its own, make an ingestible product lawful to sell as food. CBD intended for consumption has been treated as a novel food in Great Britain since 2019, which means it needs authorisation from the Food Standards Agency before it can properly be placed on the market.

In practice the sector runs on a transitional arrangement. The FSA published a public list in June 2022 covering products linked to applications that had been validated, and products on that list have been permitted to remain available while their dossiers work through safety assessment and risk management. Validated is not the same as authorised, and much of the industry, including brands with excellent laboratory practice, sits in that middle state. A handful of dossiers have since cleared safety assessment. Any retailer implying that authorisation is routine and settled is describing a regime that does not exist yet.

The gate is narrower than most people assume. Novel Foods applies to what you eat and drink: oils taken by mouth, capsules, gummies, sweets, chocolate, honey, drinks. It does not apply to CBD you inhale or apply to skin. Vapes and topicals sit under entirely different regimes, which is exactly why our vape aisle exists in the shape it does, and it is why nobody should claim Novel Foods status for a balm.

Separately, the FSA lowered its advisory intake for healthy adults from 70mg to 10mg of CBD per day, announced on 12 October 2023 after adopting advice from the Advisory Council on the Misuse of Drugs. Read it as what it is: precautionary guidance from the regulator, published as advice rather than as an enforced limit, and aimed at CBD from food supplements. It is not a recommendation from us, and nothing on this site tells you how much to take.

Spectrum is where the limit is genuinely at risk

Three grades of extract reach the shelf, and they carry three quite different levels of exposure to the container rule. Isolate is CBD with everything else stripped away. Broad spectrum keeps a range of cannabinoids and terpenes but has had THC removed. Full spectrum keeps the whole plant profile, THC included, on purpose.

Only the third grade is designed to retain the compound the law counts. That does not make full spectrum unlawful, and we list it: the owner reviewed the position in July 2026 and chose to stock it. What it does mean is that full spectrum is the only grade where compliance depends on a fresh laboratory result for the specific batch in front of you, rather than on the manufacturing process being what it says on the tin.

Container size compounds it. A full spectrum extract that comfortably clears the limit in a 10ml bottle can breach it in a 50ml one at the identical concentration, because the ceiling did not move when the bottle grew. This is the single most common way a well-intentioned product ends up non-compliant, and it is why our own certificate policy is written around per-batch documents rather than a brand-level file kept on record.

Honest caution, since nobody else in this search result seems willing to give one: if you are subject to workplace drug screening, or you drive for a living, full spectrum is not the grade to experiment with. Screening looks for THC metabolites, not for CBD, and a lawful container can still hold a genuine, if very small, quantity of THC. Isolate or a properly tested broad spectrum removes that variable. If you are not certain which grade you are holding, that uncertainty is itself the answer.

What is not legal here, whatever the label says

CBD flower and bud fail the first two limbs of the exempt product test before anyone reaches the milligram question, which is why they are not sold on this site. The June 2023 Court of Appeal ruling that CBD flower is not itself a narcotic is often quoted as though it settled the matter. It did not settle possession and supply under the Misuse of Drugs Act, and the trade position remains unresolved.

Single-use vapes have been banned across the UK since 1 June 2025 under the Environmental Protection (Single-use Vapes) Regulations 2024, and the ban is about the device rather than what is in it. A CBD disposable is caught exactly as a nicotine one is. Anyone still listing one is selling something that cannot lawfully be supplied. Rechargeable pod kits and refillable devices are the compliant replacement, and that is the whole reason our vape aisle is built around them.

Medical claims are their own offence. A CBD product marketed as doing something to a condition becomes, in the eyes of the Medicines and Healthcare products Regulatory Agency, an unlicensed medicine, and the Advertising Standards Authority polices the softer end of the same line. This is why every well-run UK CBD site, including this one, describes what a product is rather than what it might do. If a shop is willing to break that rule in its marketing, form your own view about the rules it breaks in its laboratory.

Semi-synthetic cannabinoids are the newest grey area. H4CBD is hydrogenated CBD, which makes it a different molecule from CBD, and it holds no Novel Foods authorisation of any kind. We stock a small number of H4CBD lines on an explicit decision by the owner, and we say plainly on those listings that H4CBD is not CBD and is not covered by the ingestible authorisation regime. Nobody should sell you one while implying otherwise.

Finally, everything on this page assumes an adult buyer. CBD is 18 and over, sold on an age-verified basis, and no legitimate UK retailer regards that as optional.

How to check a product yourself in about two minutes

You do not need to take a retailer's word for any of this, ours included. A compliant CBD product leaves a paper trail, and the trail is short enough to follow on a phone while you are standing in a shop.

Start with the certificate of analysis, and specifically whether it carries a batch number that matches the pack. A certificate with no batch reference describes some quantity of extract that existed at some point and says nothing whatsoever about the container you are holding. Then find the cannabinoid table and look for the total of THC and other controlled cannabinoids. If the document gives you only a percentage, multiply it by the container weight yourself using the arithmetic above, and if the result lands anywhere near one milligram, ask a harder question.

Check the laboratory is independent of the brand, and that the certificate is recent enough to plausibly cover current stock. Check the packaging matches the certificate on strength and volume. If the product is meant to be swallowed, ask where it sits with the FSA, and accept validated-and-in-progress as an honest answer, because for most of the market that is the true one.

If a seller cannot produce any of this, that is your answer, and it is worth more than any badge on a homepage. Our own position is set out in full on our lab reports page, including the parts that are still work in progress.

What is still genuinely unsettled

Pages that answer this question usually end with a confident summary. A more useful ending is a list of the things nobody can yet state with certainty, because those are where the law will actually move.

Novel Foods enforcement is the largest of them. A public list that keeps a validated but unauthorised market trading indefinitely is a transitional arrangement, and transitions end. How the FSA closes this one, and what happens to products whose dossiers do not survive assessment, is not knowable today.

Full spectrum in large containers is the second. The rule is clear; consistent per-batch evidence across the whole market is not. Our own worklist for those lines is open rather than closed, and we would rather say so than imply a certificate exists for every batch on the shelf.

The status of CBD flower remains contested after the 2023 appeal ruling, semi-synthetic cannabinoids such as H4CBD have no settled regulatory home in the UK at all, and the hemp cultivation threshold is mid-reform. None of that changes the answer at the top of this page. It does mean anyone telling you UK CBD law is simple and finished has not read it recently.